Creating some semblance of order out of the ASH18 abstracts!

This is the first of our ASH 2018 preview series and looks beyond the obvious to many off-the-reservation type of abstracts, mostly within what can be classed as early new product development of Developmental Therapeutics.

In other words, what’s coming down the pike that looks intriguing, worrying or potentially useful?

There are likely to be a few obvious candidates, but also quite a few surprises in store for the unwary…

To learn more from our latest assessment and get a heads up on our oncology insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers